908 Devices (NASDAQ:MASS) Shares Down 0.4% – Time to Sell?

908 Devices Inc. (NASDAQ:MASS) was down 0.4% during mid-day trading on Friday . The company traded as low as $5.38 and last traded at $5.40. Approximately 264,743 shares traded hands during trading, a decline of 49% from the average daily volume of 517,250 shares. The stock had previously closed at $5.42.

Analyst Ratings Changes

Several research analysts have weighed in on MASS shares. Weiss Ratings reissued a “sell (d-)” rating on shares of 908 Devices in a report on Wednesday, October 8th. Wall Street Zen upgraded 908 Devices from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $9.00.

908 Devices Trading Down 0.4%

The stock’s 50-day simple moving average is $6.03 and its 200-day simple moving average is $6.73. The stock has a market cap of $195.43 million, a price-to-earnings ratio of -49.09 and a beta of 0.48.

908 Devices (NASDAQ:MASS) last issued its quarterly earnings results on Monday, November 10th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.03). The company had revenue of $14.01 million during the quarter, compared to the consensus estimate of $13.58 million. 908 Devices had a negative net margin of 7.17% and a negative return on equity of 22.31%. On average, equities research analysts forecast that 908 Devices Inc. will post -1.99 earnings per share for the current year.

Institutional Trading of 908 Devices

Several large investors have recently modified their holdings of MASS. AQR Capital Management LLC acquired a new position in 908 Devices in the first quarter valued at about $365,000. Old Port Advisors acquired a new position in shares of 908 Devices in the 2nd quarter valued at approximately $525,000. Nisa Investment Advisors LLC raised its position in shares of 908 Devices by 453.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 3,784 shares of the company’s stock valued at $27,000 after buying an additional 3,100 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its holdings in shares of 908 Devices by 67.0% during the 2nd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 38,186 shares of the company’s stock worth $272,000 after acquiring an additional 15,324 shares during the period. Finally, ANTIPODES PARTNERS Ltd boosted its position in shares of 908 Devices by 49.7% during the 2nd quarter. ANTIPODES PARTNERS Ltd now owns 6,558 shares of the company’s stock worth $47,000 after acquiring an additional 2,176 shares in the last quarter. 88.06% of the stock is owned by institutional investors and hedge funds.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.